Status | Study |
Recruiting |
Study Name: Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias Condition: Gestational Trophoblastic Neoplasias (GTN) Date: 2017-04-06 Interventions: Drug: Avelumab administration at 10mg/kg Avelumab administration at 10 mg/kg as a 1 hour IV infusion onc |
Recruiting |
Study Name: The French National Reference Centre of GTD Condition: Neoplasm, Trophoblastic Gestational Trophoblastic Disease Date: 2016-08-02 |
Recruiting |
Study Name: Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) Condition: Gestational Trophoblastic Neoplasia Choriocarcinoma Date: 2016-01-20 Interventions: Drug: TRC105 Subjects will beg |
Not yet recruiting |
Study Name: Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor Condition: Gestational Trophoblastic Neoplasms Date: 2015-12-13 Interventions: Drug: Etoposide etoposide 100m |
Recruiting |
Study Name: Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms Condition: Gestational Trophoblastic Neoplasms Date: 2015-08-08 Interventions: Procedure: Total abdominal hysterectomy and methotrexate |
Completed |
Study Name: RCT on the Efficacy of Methotrexate for the Prevention of GTD Condition: Hydatidiform Mole Date: 2013-11-07 Interventions: Drug: Methotrexate Patients wi |
Active, not recruiting |
Study Name: Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia Condition: Gestational Trophoblastic Disease Gestati Date: 2013-03-21 Interventions: Drug: MTX 1 MTX 0.4mg/(kg· |
Active, not recruiting |
Study Name: Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Condition: Choriocarcinoma FIGO Stage I Gestational Trophoblastic Tumor Date: 2012-02-14 Interventions: Biological: Dactinomycin Given |
Recruiting |
Study Name: Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles Condition: Hydatidiform Moles Date: 2009-11-04 |
Terminated |
Study Name: Blood Samples From Patients on a Clinical Trial to CINV During HSCT Condition: Breast Cancer Chronic Myeloproliferative Disorders Date: 2009-05-09 Interventions: Other: immunoenzyme technique Other: labor |